CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 109 filers reported holding CYTOKINETICS INC in Q1 2016. The put-call ratio across all filers is 0.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,233,000 | +43.4% | 95,987 | -21.3% | 0.40% | +222.6% |
| Q1 2016 | $860,000 | -64.9% | 122,027 | -66.7% | 0.12% | -47.5% |
| Q3 2015 | $2,449,000 | -59.5% | 366,042 | -59.3% | 0.24% | -60.1% |
| Q2 2015 | $6,048,000 | +393.7% | 899,951 | +398.1% | 0.59% | +392.5% |
| Q1 2015 | $1,225,000 | +123.1% | 180,666 | +163.7% | 0.12% | +130.8% |
| Q4 2014 | $549,000 | +219.2% | 68,510 | +40.4% | 0.05% | +246.7% |
| Q3 2014 | $172,000 | +104.8% | 48,801 | +178.5% | 0.02% | +114.3% |
| Q2 2014 | $84,000 | -97.7% | 17,524 | -96.8% | 0.01% | -95.9% |
| Q4 2013 | $3,597,000 | +386.7% | 553,402 | +466.7% | 0.17% | +400.0% |
| Q3 2013 | $739,000 | – | 97,656 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |